Clinical trial · people
Thymalin: developers report 2.0-2.1-fold fewer deaths in older adults
Checked against the paper Clinical trialPublished by PepVault
The takeaway
One older trial from the peptides' own developers links Thymalin, alone or with Epithalamin, to fewer respiratory illnesses and fewer deaths in older adults than in a control group; no other group has repeated it.
- Kind
- Clinical trial
- Studied in
- People
- Number studied
- 266
- Published
- 2003
- Journal
- Neuro Endocrinol Lett
What they tested
The team wanted to know whether Thymalin, a thymus peptide, and Epithalamin, a pineal peptide, could slow aging-related decline and extend life in older people.
How the study was done
A controlled clinical trial in 266 older adults followed for 6-8 years. Groups got Thymalin, Epithalamin or both during the first 2-3 years and were compared with a control group. One separate group got the two peptides together every year for 6 years.

What they found
People given the peptides showed better measures of heart, hormone, immune and nervous system function, metabolism and homeostasis (the body's internal balance). They had 2.0-2.4-fold fewer acute respiratory illnesses than controls. They also had fewer signs of ischemic heart disease, high blood pressure, deforming osteoarthrosis and osteoporosis. Compared with controls, the death rate fell 2.0-2.1-fold with Thymalin, 1.6-1.8-fold with Epithalamin and 2.5-fold with both, and 4.1 times in the group treated with both every year for 6 years.
What it doesn’t show
The paper comes from the institute that developed both peptides, and no other group has repeated it. A comparison with a control group like this one can mislead if the groups differed at the start. This is a single study in older adults, so it says nothing about younger people. Each treatment arm was a part of 266 people, and the death-rate results are comparisons between groups, not a measure of how long any one person lives.
The paper
Khavinson and Morozov Peptides of pineal gland and thymus prolong human life. Neuro Endocrinol Lett. 2003.
The compound
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.